Urinary System Adenocarcinoma — Trials

Urinary System Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

1,629 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 378
Recruiting: 195
Ph III recruiting: 14
Growth YoY: +1.2%
Industry share: 33%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 39.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (279)

clinicaltrialsPublishedShowing 601–650 of 688 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00918281	Reproducibility of 18F Uptake by Solid Tumors Using PET Imaging Following Intravenous Administration of (18F) Injection	completed	Phase 2	70	GE HealthcareINDUSTRY	1	Jun 9, 2014	clinicaltrials
NCT00112905	Sorafenib in Treating Patients With Regional or Metastatic Cancer of the Urothelium	terminated	Phase 2	27	National Cancer Institute (NCI)NIH	1	May 30, 2014	clinicaltrials